|
Real-time Estimate
Cboe Europe
18:20:56 20/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 3,491.50 DKK | -0.16% |
|
+1.51% | +72.67% |
| 08:53am | Nordic stocks in North America - Ericsson down 1.4% | FW |
| 11-18 | Genmab A/S Presents at 8th Annual Wolfe Research Healthcare Conference, Nov-10-2026 02:00 PM |
| Market Cap | 221B 32.5B 29.61B 27.41B 24.79B 46.51B 3,035B 48.68B 331B 131B 1,640B 122B 119B 5,196B | P/E 2026 * |
41.5x | P/E 2027 * | 32.4x |
|---|---|---|---|---|---|
| Enterprise Value | 240B 35.28B 32.14B 29.76B 26.92B 50.49B 3,295B 52.85B 360B 143B 1,781B 132B 130B 5,640B | EV / Sales 2026 * |
8.01x | EV / Sales 2027 * | 6.42x |
| Free-Float |
94.31% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Copenhagen
| GMAB | Delayed | |
| GMABc | Real-time | ||
| GE9 | Real-time | ||
| GMAB N | End-of-day quote | ||
| GNMSF | Delayed | ||
| GE9 | End-of-day quote | ||
| GE9 | Real-time | ||
| GE9 | Delayed | ||
| GE9 | Delayed | ||
| 0MGB | Delayed | ||
| 0MGB | Real-time | ||
| GE9 | Delayed | ||
| GMAB | End-of-day quote |
Last Transcript: Genmab A/S
| 1 day | -0.10% | ||
| 1 week | +1.51% | ||
| Current month | -10.53% | ||
| 1 month | +34.51% | ||
| 3 months | +63.48% | ||
| 6 months | +103.19% | ||
| Current year | +72.67% |
| 1 week | 3,450 | 3,582 | |
| 1 month | 2,586 | 3,947 | |
| Current year | 1,512 | 3,947 | |
| 1 year | 1,512 | 3,947 | |
| 3 years | 1,157 | 3,947 | |
| 5 years | 1,157 | 3,947 | |
| 10 years | 786.2 | 3,947 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 01/06/2010 | |
Anthony Pagano
DFI | Director of Finance/CFO | 48 | 01/03/2020 |
Rayne Waller
CTO | Chief Tech/Sci/R&D Officer | - | 16/08/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 75 | 01/11/2003 | |
| Director/Board Member | 58 | 01/01/2015 | |
| Director/Board Member | 75 | 01/01/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 12/1/25 A | Exercice | Director | 189 | 0.0003% | ||
| 12/1/25 A | Exercice | Director | 189 | 0.0003% | ||
| 12/1/25 A | Exercice | Director | 283 | 0.0004% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.16% | +1.51% | +78.85% | +57.66% | 32.5B | ||
| -2.49% | -6.35% | +51.07% | +64.95% | 65.42B | ||
| -0.16% | -2.48% | +6.67% | +90.06% | 58.91B | ||
| -2.07% | -1.95% | +23.21% | +82.81% | 55.24B | ||
| -0.48% | -4.88% | +13.44% | +110.90% | 45.66B | ||
| -0.44% | -5.56% | +15.32% | +21.96% | 41.29B | ||
| -0.93% | +1.67% | +20.83% | +45.03% | 36.82B | ||
| +4.40% | -3.57% | +137.75% | +664.57% | 34.48B | ||
| -0.43% | +20.81% | -26.68% | +494.54% | 31.69B | ||
| -6.57% | -16.20% | +28.32% | -13.31% | 22.93B | ||
| Average | -0.92% | -1.62% | +34.88% | +161.92% | 42B | |
| Weighted average by Cap. | -0.88% | -1.77% | +33.29% | +145.70% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 29.99B 4.4B 4.01B 3.71B 3.36B 6.3B 411B 6.6B 44.89B 17.81B 222B 16.52B 16.17B 704B | 36.34B 5.34B 4.86B 4.5B 4.07B 7.64B 498B 7.99B 54.4B 21.58B 269B 20.02B 19.6B 853B |
| Net income | 5.33B 783M 713M 660M 597M 1.12B 73.1B 1.17B 7.98B 3.17B 39.5B 2.94B 2.87B 125B | 7.05B 1.03B 943M 873M 789M 1.48B 96.63B 1.55B 10.55B 4.18B 52.22B 3.88B 3.8B 165B |
| Net Debt | 18.93B 2.78B 2.53B 2.34B 2.12B 3.98B 260B 4.16B 28.34B 11.24B 140B 10.43B 10.21B 444B | 11.78B 1.73B 1.58B 1.46B 1.32B 2.48B 162B 2.59B 17.64B 7B 87.33B 6.49B 6.36B 277B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/11/26 | DKK 3,503.00 | +0.17% | 42,577 |
| 19/11/26 | DKK 3,497.00 | +0.03% | 119,495 |
| 18/11/26 | DKK 3,496.00 | -0.17% | 114,462 |
| 17/11/26 | DKK 3,502.00 | -0.77% | 152,354 |
| 16/11/26 | DKK 3,529.00 | +2.35% | 152,134 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- GMAB Stock
Select your edition
All financial news and data tailored to specific country editions




















